-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OLpUAav5DWajQBgzrqzrcb7IN8CMNCKLM3KZ9xG1GjBjlK0XjT+9iq+AkL14s5vP
 b7NzV+Be7IN0gG+RngoUXw==

<SEC-DOCUMENT>0001157523-10-003035.txt : 20100510
<SEC-HEADER>0001157523-10-003035.hdr.sgml : 20100510
<ACCEPTANCE-DATETIME>20100510172540
ACCESSION NUMBER:		0001157523-10-003035
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20100510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100510
DATE AS OF CHANGE:		20100510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANIKA THERAPEUTICS INC
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		10817756

	BUSINESS ADDRESS:	
		STREET 1:		236 WEST CUMMINGS PARK
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801
		BUSINESS PHONE:		6179326616

	MAIL ADDRESS:	
		STREET 1:		236 WEST CUMMINGS PARK
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a6285006.htm
<DESCRIPTION>ANIKA THERAPEUTICS, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <hr style="height: 1.0 pt; text-align: center; color: #000000; width: 100%">
    <hr style="height: 1.0 pt; text-align: center; color: #000000; width: 100%">


    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman">UNITED STATES</font><font style="font-size: 12pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 12pt"></font><font style="font-size: 12pt; font-family: Times New Roman">SECURITIES
      AND EXCHANGE COMMISSION</font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt">Washington, D.C. 20549</font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman">FORM 8-K</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt">CURRENT REPORT</font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-size: 12pt">PURSUANT
      TO SECTION 13 OR 15(d)</font><br><font style="font-size: 12pt">OF THE
      SECURITIES EXCHANGE ACT OF 1934</font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 11pt; font-family: Times New Roman">Date of
      Report (Date of earliest event reported): May 10, 2010</font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt">Anika Therapeutics, Inc.</font><br><i>(Exact
      name of registrant as specified in its charter)</i>
    </p>
    <hr style="height: 1.0 pt; text-align: center; color: #000000; width: 20%">


    <p style="text-align: center">

    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-family: Times New Roman; width: 100%; font-size: 10pt; margin-bottom: 10.0px">
      <tr>
        <td valign="bottom" style="width: 33%; padding-left: 0.0px; text-align: center">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Massachusetts
          </p>
        </td>
        <td valign="bottom" style="width: 34%; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            000-21326
          </p>
        </td>
        <td valign="bottom" style="width: 33%; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            04-3145961
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 33%; padding-left: 0.0px; text-align: center">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <i>(State or other jurisdiction of<br>incorporation or
            organization)</i>
          </p>
        </td>
        <td valign="top" style="width: 34%; padding-left: 0.0px; text-align: center">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <i>Commission file number</i>
          </p>
        </td>
        <td valign="top" style="width: 33%; padding-left: 0.0px; text-align: center">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <i>(I.R.S. Employer<br>Identification No.)</i>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      32 Wiggins Avenue, Bedford, MA 01730<br><i>(Address of principal
      executive offices) (Zip code)</i>
    </p>
    <p style="text-align: center">
      <i>Registrant&#8217;s telephone number, including area code:&#160;&#160;&#160;</i>781-457-9000
    </p>
    <p style="text-align: center">
      <br>
      <i>(Former name or former address, if changed since last report)</i>
    </p>
    <hr style="color: #000000; width: 20%; text-align: center; height: 1.0 pt">


    <p style="text-align: center">

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font><br><font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font><br><font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font><br><font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font><br><br>
    </p>
    <hr style="color: #000000; width: 100%; text-align: center; height: 1.0 pt">
    <hr style="color: #000000; width: 100%; text-align: center; height: 1.0 pt">


    <p>
      <br>

    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      <b>Section 2--Financial Information</b>
    </p>
    <p style="white-space: nowrap">
      Item 2.02.&#160;&#160;Results of Operations and Financial Condition.
    </p>
    <p>
      The following information, including the exhibit attached hereto, is
      intended to be furnished and shall not be deemed &quot;filed&quot; for purposes of
      Section 18 of the Securities Exchange Act of 1934 (the &quot;Exchange Act&quot;)
      or otherwise subject to the liabilities of that section, nor shall it be
      deemed incorporated by reference in any filing under the Securities Act
      of 1933 or the Exchange Act, except as expressly set forth by specific
      reference in such filing.
    </p>
    <p>
      On May 10, 2010, Anika Therapeutics, Inc. issued a press release
      announcing its financial results for the first quarter ended March 31,
      2010.&#160;&#160;The full text of the press release is furnished as Exhibit 99.1
      hereto and is incorporated herein by reference.
    </p>
    <p style="text-align: center">
      <br>
      <b>Section 9--Financial Statements and Exhibits</b>
    </p>
    <p>

    </p>
    <p style="white-space: nowrap">
      Item 9.01.&#160;&#160;Financial Statements and Exhibits.
    </p>
    <p style="white-space: nowrap">
      (d)&#160;&#160;Exhibits.
    </p>
    <p style="white-space: nowrap">
      99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press Release of Anika Therapeutics, Inc. dated May 10,
      2010.
    </p>
    <p style="margin-left: 60.0px; white-space: nowrap">

    </p>
    <p style="text-align: center">
      <br>
      <br>
      [Remainder of page left blank intentionally]
    </p>
    <p style="text-align: center">
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>

    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt">SIGNATURE</font><br>
    </p>
    <p>
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned, hereunto duly authorized.
    </p>
    <p>

    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%; margin-bottom: 10.0px">
      <tr>
        <td style="width: 5%">
          &#160;
        </td>
        <td style="width: 43%">

        </td>
        <td colspan="2" valign="top" style="padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Anika Therapeutics, Inc.
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 43%">

        </td>
        <td colspan="2">

        </td>
        <td style="width: 15%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 43%">

        </td>
        <td colspan="2" valign="top" style="padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td colspan="2" valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Dated: May 10, 2010
          </p>
        </td>
        <td valign="top" style="padding-bottom: 2.0px; width: 7%; padding-left: 0.0px; text-align: left">
          By:
        </td>
        <td valign="top" style="width: 30%; border-bottom: solid black 1.0pt; padding-left: 15.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Kevin W. Quinlan
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 43%">

        </td>
        <td valign="top" style="width: 7%; padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="width: 30%; padding-left: 15.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Kevin W. Quinlan
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 43%">

        </td>
        <td valign="top" style="width: 7%; padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="width: 30%; padding-left: 15.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Financial Officer
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 7%">

        </td>
        <td valign="top" style="width: 30%; padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      Exhibit Index
    </p>
    <p>

    </p>
    <p>
      99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press Release of Anika Therapeutics, Inc. dated May 10, 2010.
    </p>
    <p style="margin-left: 60.0px; white-space: nowrap">

    </p>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a6285006-ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>Anika
      Therapeutics Reports 35% Total Revenue Growth in First Quarter 2010</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <i><font style="font-size: 12pt; font-family: Times New Roman"><b>Strong
      Domestic Sales of ORTHOVISC</b></font><b><sup><font style="font-family: Times New Roman; font-size: 12pt">&#174;
      </font></sup><font style="font-family: Times New Roman; font-size: 12pt">Drive
      18% Organic Product Growth; Company Completes Initial Steps in FAB
      Integration Plan</font></b></i>
    </p>
    <p style="text-align: center">

    </p>
    <p>
      BEDFORD, Mass.--(BUSINESS WIRE)--May 10, 2010--<u>Anika Therapeutics, Inc</u>.
      (Nasdaq: ANIK), a leader in products for tissue protection, healing, and
      repair, based on <u>hyaluronic acid</u> (&#8220;HA&#8221;) technology, today
      reported financial results for the quarter ended March 31, 2010.
    </p>
    <p>
      <b>Key Highlights</b>
    </p>
    <ul>
      <li style="margin-bottom: 10.0px">
        Total revenue and product revenue grew 35% and 37%, respectively
      </li>
      <li style="margin-bottom: 10.0px">
        Orthopedic/joint health revenue rose 34%, driven by strong U.S. sales
        of ORTHOVISC<sup><i><b>&#174;</b></i></sup>
      </li>
      <li style="margin-bottom: 10.0px">
        Achieved good progress on FAB integration and product rationalization
      </li>
    </ul>
    <p>
      <b>Revenue</b>
    </p>
    <p>
      Anika&#8217;s product revenue increased 37% to $11.6 million for the first
      quarter of 2010, from $8.5 million in the first quarter of 2009.
      Excluding revenue from Fidia Advanced Biopolymers, s.r.l. (&#8220;FAB&#8221;), which
      was acquired by Anika late in the fourth quarter of 2009, product
      revenue increased 18% from the year-earlier quarter. This growth was
      primarily due to continued strong U.S. sales of the Company&#8217;s <u>ORTHOVISC</u><sup><b>&#174;</b></sup>
      product line.
    </p>
    <p>
      Total revenue for the first quarter of 2010 grew 35% to $12.5 million,
      from $9.2 million in the first quarter last year.
    </p>
    <p>
      <b>Product Gross Margin</b>
    </p>
    <p>
      Product gross margin for the first quarter of 2010 was 56%, compared
      with 62% in last year&#8217;s first quarter. The decrease in product gross
      margin largely reflected the addition of FAB products into Anika&#8217;s
      overall product mix.
    </p>
    <p>
      <b>Operating Expenses</b>
    </p>
    <p>
      Research and development expenses for the first quarter of 2010
      decreased to $1.9 million, from $2.2 million in the first quarter of
      2009. This reflected a decline in R&amp;D spending due to the completion of
      Anika&#8217;s U.S. MONOVISC clinical trial in the third quarter of 2009,
      partially offset by the inclusion of FAB expenses.
    </p>
    <p>
      Selling, general and administrative expenses for the first quarter of
      2010 increased to $4.3 million from $3.0 million in the same quarter of
      2009, driven by the inclusion of SG&amp;A costs at FAB. Excluding FAB,
      Anika&#8217;s first-quarter 2010 SG&amp;A expenses were essentially level with the
      year-earlier quarter.
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <b>Net Income</b>
    </p>
    <p>
      Net income for the first quarter of 2010 was $714,000, or $0.05 per
      diluted share, compared with $523,000, or $0.05 per diluted share, for
      the same period last year. The comparison with the first quarter of 2009
      was negatively impacted by the dilutive effect of the FAB acquisition.
    </p>
    <p>
      <b>Cash and Cash Equivalents</b>
    </p>
    <p>
      Anika&#8217;s cash and cash equivalents at March 31, 2010 were $23.2 million,
      compared with $24.4 million on December 31, 2009.
    </p>
    <p>
      <b>Management Commentary</b>
    </p>
    <p>
      &#8220;This was a great start to a year that promises to be full of milestones
      for Anika,&#8221; said Charles H. Sherwood, Ph.D., president and chief
      executive officer. &#8220;Driven by strong domestic sales of ORTHOVISC,
      organic revenue grew 18% from the first quarter of 2009. At the same
      time, we made excellent progress on our key goals for 2010, highlighted
      by completing the initial steps in our integration and product
      rationalization plan for the Fidia Advanced Biopolymers (FAB) business
      we acquired late in the fourth quarter of 2009.&#8221;
    </p>
    <p>
      &#8220;The first of our 2010 goals is to grow sales of ORTHOVISC in the United
      States and internationally,&#8221; said Sherwood. &#8220;ORTHOVISC continued to
      perform well in the first quarter of 2010, particularly in the United
      States, where sales were up 44% from the first quarter last year.
      Second, we expect a U.S. launch of MONOVISC using a hybrid sales model
      in the second half of 2010 following PMA approval from the FDA.&#8221;
    </p>
    <p>
      &#8220;Our third key goal for this year is to obtain FDA approval and launch
      key FAB products in the United States,&#8221; Sherwood said. &#8220;FAB has a broad
      orthopedic portfolio that, added to ORTHOVISC and MONOVISC, should
      provide us with the critical mass of products we need to more
      effectively penetrate the U.S. market.&#8221;
    </p>
    <p>
      &#8220;Anika&#8217;s vision is to offer therapeutic products that span the full
      continuum of care &#8211; from palliative, to protective, to restorative or,
      in other words, from pain relief to protecting and restoring damaged
      tissue,&#8221; said Sherwood. &#8220;FAB&#8217;s restorative tissue technology products
      will help us advance this vision. Our fourth goal for 2010 is to expand
      sales of these products beyond Italy, where they are currently
      commercialized, into other European markets.&#8221;
    </p>
    <p>
      &#8220;Our fifth goal for 2010 is to reduce FAB&#8217;s operating loss through cost
      synergies and product rationalization, positioning FAB to generate
      profits in 2011,&#8221; Sherwood said. &#8220;Our efforts in this area are focused
      on integrating FAB&#8217;s research and development pipeline and manufacturing
      operations with Anika&#8217;s, while rationalizing FAB&#8217;s product portfolio. We
      made progress in each of these areas in the first quarter, highlighted
      by the first steps toward consolidation of our R&amp;D activities on both
      sides of the Atlantic.&#8221;
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      &#8220;As we begin the second quarter, we are successfully executing on our
      key goals and driving revenue growth, leveraging our HA research and
      manufacturing expertise and our solid financial position,&#8221; said
      Sherwood. &#8220;FAB advances our vision to provide innovative therapeutic
      products that go beyond pain relief, expanding our growth opportunities
      and positioning us for accelerated earnings in the long-term. We are
      looking forward to making further progress as 2010 unfolds.&#8221;
    </p>
    <p>
      <b>Conference Call Information</b>
    </p>
    <p>
      Anika will hold a conference call to discuss its financial results,
      business highlights and outlook tomorrow, Tuesday, May 11, 2010 at 9:00
      a.m. ET. In addition, the Company will answer questions concerning
      business and financial developments and trends, and other business and
      financial matters affecting the Company, some of the responses to which
      may contain information that has not been previously disclosed.
    </p>
    <p>
      To listen to the conference call, 888-396-2356 (International callers
      dial 617-847-8709) and use the passcode 66039281. Please call
      approximately 10 minutes before the starting time and reference Anika
      Therapeutics. In addition, the conference call will be available to
      interested parties through a live audio webcast in the <u>&#8220;Investor
      Relations&#8221;</u> section of the Anika Therapeutics website, <u>www.anikatherapeutics.com</u>.
      An accompanying slideshow presentation also can be accessed via the
      Anika Therapeutics website. The call will be archived and accessible on
      the same website shortly after the conclusion of the call.
    </p>
    <p>
      <b>About Anika Therapeutics, Inc.</b>
    </p>
    <p>
      Headquartered in Bedford, Mass., <u>Anika Therapeutics, Inc</u>.
      develops, manufactures and commercializes therapeutic products for
      tissue protection, healing, and repair. These products are based on <u>hyaluronic
      acid (HA)</u>, a naturally occurring, biocompatible polymer found
      throughout the body. Anika&#8217;s products range from orthopedic/joint health
      solutions led by <u>ORTHOVISC</u><sup>&#174;</sup>, a treatment for
      osteoarthritis of the knee; to surgical aids in the <u>ophthalmic</u>
      and <u>anti-adhesion</u> fields. The company also offers <u>aesthetic
      dermal fillers</u> for the correction of facial wrinkles. Anika&#8217;s
      Italian subsidiary, Fidia Advanced Biopolymers, S.r.l (FAB), provides
      complementary HA products in orthopedic/joint health and anti-adhesion,
      as well as therapeutics in new areas such as advanced wound treatment
      and ear, nose and throat care. FAB&#8217;s regenerative tissue technology
      advances Anika&#8217;s vision to offer therapeutic products that go beyond
      pain relief to protect and restore damaged tissue.
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <i>The statements made in this press release which are not statements of
      historical fact are forward-looking statements within the meaning of
      Section 27A of the Securities Act of 1933 and Section 21E of the
      Securities Exchange Act of 1934, including, without limitation,
      statements that may be identified by words such as &quot;expectations,&quot;
      &quot;remains,&quot; &quot;focus,&quot; &quot;expected,&quot; &quot;prospective,&quot; &quot;expanding,&quot; &quot;building,&quot;
      &quot;continue,&quot; &quot;progress,&quot; &#8220;plan,&#8221; &quot;efforts,&quot; &quot;hope,&quot; &quot;believe,&quot;
      &quot;objectives,&quot; &quot;opportunities,&quot; &quot;will,&quot; &quot;seek,&quot; &#8220;expect&#8221; and other
      expressions which are predictions of or indicate future events and trends</i>
      <i>do not constitute historical matters and identify forward-looking
      statements.</i> <i>These statements also include those relating to: (i)
      the expectation that 2010 will be a year of milestones for Anika, (ii)
      the expectation that sales of ORTHOVISC will increase in the United
      States and internationally, (iii) obtaining PMA approval for, and
      commercially launching, MONOVISC in the United States, (iv) obtaining
      FDA approval and launching key FAB products in the United States using a
      hybrid sales model, (v) expanding sales of FAB&#8217;s restorative tissue
      technology products into European markets beyond Italy, (vi) reducing
      FAB&#8217;s operating loss through cost synergies and product rationalization,
      positioning FAB to generate profits in 2011, (vii) the expectation that
      Anika will successfully execute on the Company&#8217;s five key goals for 2010
      and drive revenue growth, including the integration of FAB&#8217;s research
      and development pipeline and manufacturing operations with Anika&#8217;s, and
      (viii) the expectation that Anika will make further progress as 2010
      unfolds.</i> <i>These statements are based upon the current beliefs and
      expectations of the Company's management and are subject to significant
      risks, uncertainties and other factors.</i> <i>The Company's actual
      results could differ materially from any anticipated future results,
      performance or achievements described in the forward-looking statements
      as a result of a number of factors including: (i) Coapt Systems ability
      to effectively sell Hydrelle; (ii) the Company's ability to successfully
      commence and/or complete clinical trials of its products on a timely
      basis or at all, obtain clinical data to support a pre-market approval
      application or timely file and receive FDA or other regulatory approvals
      of its products, or that such approvals will not be obtained in a timely
      manner or without the need for additional clinical trials; (iii) the
      Company's research and product development efforts and their relative
      success, including whether the Company has any meaningful sales of any
      new products resulting from such efforts; (iv) the cost effectiveness
      and efficiency of our manufacturing operations and production planning;
      (v) the strength of the economies in which the Company operates or will
      be operating, as well as the political stability of any of those
      geographic areas; (vi) future determinations by the Company to allocate
      resources to products and in directions not presently contemplated or
      (vii) the Company&#8217;s ability to launch MONOVISC in the U.S., if at all.</i>
      <i>Any delay in receiving any regulatory approvals may adversely affect
      the Company's competitive position.</i> <i>Even if regulatory approvals
      are obtained, there is a risk that meaningful sales of the products may
      not be achieved.</i> <i>There is also a risk that (i) the Company's
      existing distributors or customers will not continue to place orders at
      historical levels or that any of them will seek to modify or terminate
      existing arrangements, (ii) the Company's efforts to enter into
      long-term marketing and distribution arrangements, including with new
      international distributors for ORTHOVISC and MONOVISC, will not be
      successful, (iii) new distribution arrangements will not result in
      meaningful sales of the Company's products, (iv) the Company&#8217;s
      distributors will be unable to achieve performance and sales threshold
      milestones in its distribution agreements, (v) competitive products will
      adversely impact the Company's product sales, (vi) the estimated size(s)
      of the markets which the Company has targeted its products will fail to
      be achieved, (vii) lack of adequate coverage and reimbursement provided
      by governments and other third party payers for our products and
      services could have a material adverse effect on our results of
      operations, or (viii) increased sales of the Company's products,
      including HYVISC, ORTHOVISC , or its ophthalmic products, will not
      continue or sales will decrease or not reach historical sales levels, or
      even if such increases occur that such increases will improve gross
      margins, any of which may have a material adverse effect on the
      Company's business and operations.</i> <i>Certain other factors that
      might cause the Company's actual results to differ materially from those
      in the forward-looking statements include those set forth under the
      headings &quot;Business,&quot; &quot;Risk Factors&quot; and &quot;Management's Discussion and
      Analysis of Financial Condition and Results of Operations&quot; in the
      Company's Annual Report on Form 10-K for the year ended December 31,
      2009, as well as those described in the Company's other press releases
      and SEC filings.</i>
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%">
      <tr>
        <td colspan="14" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Anika Therapeutics, Inc. and Subsidiaries</b>
        </td>
      </tr>
      <tr>
        <td colspan="14" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Consolidated Statements of Operations</b>
        </td>
      </tr>
      <tr>
        <td colspan="14" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>(unaudited)</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="2">

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="11" valign="top" style="padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>Quarter Ended</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="11" valign="top" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>March 31,</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2010</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2009</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>% Change</b>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Product revenue
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,642,050
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,519,073
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Licensing, milestone and contract revenue
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          824,037
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          681,251
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          21
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Total revenue
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          12,466,087
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          9,200,324
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          35
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Operating expenses:
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Cost of product revenue
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5,123,675
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          3,211,666
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          60
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Research &amp; development
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,875,644
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,194,308
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          -15
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 15.0px; text-align: left">
          Selling, general &amp; administrative
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          4,288,978
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          3,034,982
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          41
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Total operating expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,288,297
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,440,956
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          34
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Income from operations
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,177,790
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          759,368
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          55
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 15.0px; text-align: left">
          Interest income (expense), net
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          (49,920
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          )
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,440
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2" style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Income before income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,127,870
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          760,808
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          48
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 15.0px; text-align: left">
          Provision for income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          413,590
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          238,088
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          74
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 4.0px; padding-left: 0.0px; text-align: left">
          Net income
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          714,280
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          522,720
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Basic net income per share:
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Net income
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0.06
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0.05
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Basic weighted average common shares outstanding
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          12,614,808
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,366,545
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Diluted net income per share:
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Net income
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0.05
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0.05
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 15.0px; text-align: left">
          Diluted weighted average common shares outstanding
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          13,628,376
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,496,518
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%">
      <tr>
        <td colspan="13" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Anika Therapeutics, Inc. and Subsidiaries</b>
        </td>
      </tr>
      <tr>
        <td colspan="13" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Consolidated Balance Sheets</b>
        </td>
      </tr>
      <tr>
        <td colspan="13" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>(unaudited)</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="top" style="padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>March 31,</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="top" style="padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>December 31,</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2010</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2009</b>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: center">
          <b>ASSETS</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Current assets:
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Cash and cash equivalents
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          23,167,641
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          24,426,990
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Accounts receivable, net
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          12,706,601
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,831,438
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Inventories
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,785,265
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,441,079
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Current portion deferred income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,183,827
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,183,827
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 10.0px; text-align: left">
          Prepaid expenses and other
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,934,507
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,921,283
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 50.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Total current assets
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          49,777,841
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          49,804,617
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Property and equipment, at cost
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          47,750,361
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          47,172,403
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Less: accumulated depreciation
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          (11,747,765
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          )
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          (11,424,788
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          )
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          36,002,596
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          35,747,615
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Long-term deposits and other
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          414,202
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          413,228
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Intangible asset, net
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          31,059,216
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          33,577,451
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Deferred income taxes
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,805,632
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          3,506,362
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Goodwill
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          7,182,830
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          7,652,253
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 4.0px; padding-left: 0.0px; text-align: left">
          Total Assets
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          127,242,317
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          130,701,526
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: center">
          <b>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</b>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Accounts payable
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          7,013,929
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6,366,944
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Accrued expenses
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          4,664,747
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5,816,170
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Deferred revenue, current
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,700,000
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,751,467
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Long-term debt, current
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,600,000
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,600,000
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 50.0px; text-align: left">
          Total current liabilities
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          15,978,676
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          16,534,581
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Other long-term liabilities
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,820,653
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1,818,383
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Long-term deferred revenue
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          7,424,996
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,099,996
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Deferred tax liability
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,336,619
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          9,305,064
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Long-term debt
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          12,400,000
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          12,800,000
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Stockholders&#8217; equity
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Preferred stock
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          &#8212;
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          &#8212;
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Common stock
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          134,590
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          134,188
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Additional paid-in-capital
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          61,021,738
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          60,539,768
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 10.0px; text-align: left">
          Accumulated currency translation adjustment
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          (2,058,781
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          )
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          &#8212;
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 10.0px; text-align: left">
          Retained earnings
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          22,183,826
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          21,469,546
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 50.0px; text-align: left">
          Total stockholders&#8217; equity
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          81,281,373
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          82,143,502
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 4.0px; padding-left: 0.0px; text-align: left">
          Total Liabilities and Stockholders&#8217; Equity
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          127,242,317
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          130,701,526
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; margin-bottom: 10pt; width: 100%; text-indent: 0pt; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <div style="text-align:left">
    <table cellspacing="0" style="font-size: 8pt; font-family: Times New Roman; margin-bottom: 10.0px; width: 100%">
      <tr>
        <td>

        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="2">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="3">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="2">

        </td>
        <td>
          &#160;
        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td colspan="19" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Anika Therapeutics, Inc. and Subsidiary</b>
        </td>
      </tr>
      <tr>
        <td colspan="19" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Supplemental Financial Data -</b>
        </td>
      </tr>
      <tr>
        <td colspan="19" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>(unaudited)</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td colspan="19" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Revenue by Product Line and Product Gross Margin</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="16" valign="top" style="padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>Quarter Ended</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="16" valign="top" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>March 31,</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2010</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>% Ttl</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2009</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>% Ttl</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>%</b><br><b>Change</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Orthopedic/Joint Health
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6,921,494
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          59
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5,149,642
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          60
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          34
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Advanced Wound Care
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          688,694
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          -
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          -
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Ophthalmic
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,584,458
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          22
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,645,252
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          31
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          -2
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Post Surgical
          </p>
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          578,547
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          36,750
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          0
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          -
        </td>
        <td>

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Aesthetics
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          197,513
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          50,094
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          1
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          294
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          Veterinary
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          671,344
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          637,335
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,642,050
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          100
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,519,073
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          100
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Product gross profit
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6,518,375
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          5,307,407
        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Product gross margin
        </td>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          56
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          62
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td colspan="9" valign="top" style="padding-left: 0.0px; text-align: center">
          <b>Product Revenue by Geography</b>
        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="3">

        </td>
        <td>

        </td>
        <td colspan="2">

        </td>
        <td>

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="16" valign="top" style="padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>Quarter Ended</b>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="16" valign="top" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>March 31,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2010</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>% Ttl</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="3" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>2009</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <b>% Ttl</b>
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td colspan="2" valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: center; padding-right: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>%</b><br><b>Change</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left">
          Domestic
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,378,266
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          72
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          6,135,564
        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          72
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td>

        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-bottom: 2.0px; padding-left: 0.0px; text-align: left">
          International
        </td>
        <td>

        </td>
        <td>

        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          3,263,784
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          28
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          2,383,509
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          28
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: solid black 1.0pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="border-bottom: solid black 1.0pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
      <tr>
        <td>

        </td>
        <td>

        </td>
        <td>

        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          11,642,050
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          100
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          $
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          8,519,073
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          100
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
        <td style="border-bottom: double black 2.25pt">
          &#160;
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: right; padding-right: 0.0px">
          37
        </td>
        <td valign="bottom" style="border-bottom: double black 2.25pt; padding-left: 0.0px; white-space: nowrap; text-align: left; padding-right: 0.0px">
          %
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>
      CONTACT:<br>Anika Therapeutics, Inc.<br>Charles H. Sherwood, Ph.D.,
      781-457-9000<br>CEO<br>or<br>Kevin W. Quinlan, 781-457-9000<br>CFO
    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
